Latest Breaking News On - Gain therapeutics - Page 6 : comparemela.com

Hansa Biopharma AB: Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

Hansa Biopharma AB: Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaUnited statesEvan ballantyneKlaus sindahlHansa biopharmaPrnewswire hansa biopharmaDonato spotaStephanie kenneyUniversity of western ontarioGain therapeutics incVp global corporate affairsHonors business administrationUniversity of windsorHansa executive committeePreveceutical medical inc

Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer

/PRNewswire/ Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced the appointment of Evan Ballantyne as Chief Financial Officer (CFO),.

United statesUnited kingdomBritish columbiaPrnewswire hansa biopharmaStephanie kenneyDonato spotaEvan ballantyneKlaus sindahlHansa biopharmaHansa executive committeePreveceutical medical incHonors business administrationUniversity of windsorGain therapeutics incVp global corporate affairsUniversity of western ontario

Gain Therapeutics Announces 2024 R&D Update on Parkinson s Disease with KOL & Analyst Insight

Gain Therapeutics Announces 2024 R&D Update on Parkinson s Disease with KOL & Analyst Insight
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tel avivHartaj singhEka gigauriJoanne taylorNic johnsonRoy alcalayTiago fleming outeiroMatthias alderElio ambrosioSilverstein foundation for parkinsonResearch developmentMovement disorder societyUniversity medical centerColumbia universityMichaelj fox foundation for parkinson researchDepartment of experimental neurodegeneration

Gain Therapeutics Announces 2024 R&D Update on Parkinson s Disease with KOL & Analyst Insight -February 14, 2024 at 12:30 pm EST

Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 Gain Therapeutics, Inc., , a.

Tel avivHartaj singhJoanne taylorEka gigauriRoy alcalayMatthias alderElio ambrosioNic johnsonTiago fleming outeiroOppenheimer coColumbia universityCompany annual report on formMovement disorder societyGain therapeutics incDepartment of experimental neurodegenerationSilverstein foundation for parkinson

Gain Therapeutics (GANX) GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson s Disease

Gain Therapeutics (GANX) GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMatthias alderGain therapeutics incDrug administrationGain therapeuticsGain therapeutic chief executiveNeurofilament light chain